REBIOTIX MICROBIOTA RESTORATION THERAPY & DESIGN (1)

View On IC.GC.CA

REGISTERED

on 7 Apr 2022

Last Applicant/ Owned by

FERRING BV A DUTCH COMPANY

Polarisavenue 130 - 1442132 JX Hoofddopr

Serial Number

1946798 filed on 19^th Feb 2019

Registration Number

TMA1125386 registered on 7^th Apr 2022

Registration expiry Date

7^th Apr 2032

Correspondent Address

CASSELS BROCK & BLACKWELL LLP

Suite 3200, Bay Adelaide Centre - North Tower40 Temperance St.Toronto,

ONTARIO

M5H0B4

REBIOTIX MICROBIOTA RESTORATION THERAPY & DESIGN (1)

Trademark usage description

pharmaceutical and biopharmaceutical agents used for the treatment of digestive system diseases and disorders; pharmaceutical and biopharmaceutical ag Read More

Vienna Information

26 . 1 . 1

CirclesCercles

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 7

Letters surmounted by a sign of disproportionate size -- Note: Includes, for instance, a letter i surmounted by a disproportionate dot, by a star or a flower.Lettres surmontées d'un signe de dimension disproportionnée -- Note: Comprend par exemple la lettre i surmontée d'un point disproportionné, d'une étoile ou d'une fleur.

26 . 4 . 2

RectanglesRectangles

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

Classification Information

Class [005]
Pharmaceutical and biopharmaceutical agents used for the treatment of digestive system diseases and disorders; pharmaceutical and biopharmaceutical agents used for the treatment of diseases and disorders in the fields of gastroenterology; pharmaceutical preparations for treating gastrointestinal diseases and disorders, namely, gastrointestinal anti-inflammatory preparations; pharmaceutical preparations for the treatment of checkpoint inhibitor mediated colitis; pharmaceutical preparations for the treatment of reproductive health, namely, fertility enhancement preparations for human use, preparations for treating recurrent vaginosis, preparations for treating pregnancy complications; pharmaceutical preparations for the treatment of urinary tract infections; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia, nervosa, anorexia, obesity, hypothyroidism; pharmaceutical preparations for the treatment of diseases, disorders, and infections of the endocrine system, namely, growth and thyroid disorders; pharmaceutical preparations for the treatment of liver cancer; pharmaceutical preparations for the treatment of hepatic encephalopathy; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; pharmaceutical and biopharmaceutical agents used for the treatment of gastrointestinal diseases and disorders

Classification kind code

Class [042]
Medical research; scientific research in the field of genetics and genetic engineering; providing medical and scientific research information in the field of clinical trials.

Classification kind code

Mark Details

Serial Number

1946798

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 29^th Dec 2021	Advertised
Submitted for opposition 48 on 20^th Dec 2021	Agent Changed
Submitted for opposition 26 on 23^rd Nov 2021	Approved
Submitted for opposition 27 on 23^rd Nov 2021	Approval Notice Sent
Submitted for opposition 22 on 19^th Apr 2021	Search Recorded
Submitted for opposition 20 on 19^th Apr 2021	Examiner's First Report
Submitted for opposition 80 on 17^th Sept 2019	Change of Title Registered
Submitted for opposition 31 on 20^th Feb 2019	Formalized
Submitted for opposition 30 on 19^th Feb 2019	Filed
Submitted for opposition 1 on 19^th Feb 2019	Created

REBIOTIX MICROBIOTA RESTORATION THERAPY & DESIGN (1)

Classification Information

Classification kind code

Class [042]Medical research; scientific research in the field of genetics and genetic engineering; providing medical and scientific research information in the field of clinical trials.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [042]
Medical research; scientific research in the field of genetics and genetic engineering; providing medical and scientific research information in the field of clinical trials.